A multiunit matrix-based particulate system for controlled delivery of nifedipine

Pharmaceutical Technology

Volumn 28, Issue 11, 2004, Pages 84-102

  Sood, Anurag ^a   Ashokraj, Yasvanth ^b   Panchagnula, Ramesh ^b  

^a RANBAXY RESEARCH LABORATORIES   (India)

^b Department of Pharmaceutics   (India)

Author keywords

[No Author keywords available]

Indexed keywords

DRUG DOSAGE; PARTICLES (PARTICULATE MATTER); SOLUBILITY; WATER;

MATRIX-BASED PARTICULATE SYSTEMS; NIFEDIPINE;

DRUG PRODUCTS;

NIFEDIPINE; WATER;

ARTICLE; CONTROLLED DRUG RELEASE; DRUG DELIVERY SYSTEM; DRUG SCREENING; EXTRACELLULAR MATRIX; SOLUBILITY;

EID: 9644276814     PISSN: 15432521     EISSN: None     Source Type: Journal    
DOI: None     Document Type: Article

References (23)

1. P. DeHaan and C.F. Lerk, "Oral Controlled Release Dosage Forms: A Review," Pharm. Weekbl Sci. Ed. 6, 57-67 (1984).
2. V.H.K. Li and V.H.L. Lee, "Influence of Drug Properties and Routes of Drug Administration on the Design of Sustained and Controlled Release Systems," in Controlled Drug Delivery: Fundamentals and Applications, J.R Robinson and V.H.L. Lee, Eds. (Marcel Dekker, Inc., New York, NY, 1987), pp. 3-94.
3. T. Salsa, F. Veiga, and M.E. Pinaa, "Oral Controlled-Release Dosage Forms: I. Cellulose Ether Polymers in Hydrophilic Matrices," Drug Dev. Ind. Pharm. 23 (9), 929-938 (1997).
4. I. Ghebre-Sellassie and A. Knoch, "Pelletization Techniques," in Encyclopedia of Pharmaceutical Technology, J. Swarbrick and J.C. Boylan, Eds. (Marcel Dekker, Inc, New York, NY, 1995), pp. 369-394.
5. A. Sood, Y. Ashokraj, and R Panchagnula, "Use of Extrusion-Spheronization to Develop Controlled-Release Dosage Forms for Diltiazem Hydrochloride," Pharm. Techol. 28 (4), 62-84 (2004).
6. W.A. Ritschel, "Biopharmaceutic and Pharmacokinetic Aspects in the Design of Controlled Release Peroral Drug Delivery Systems," DrugDev. Ind. Pharm. 15 (6,7), 1073-1103 (1989).
7. M. Gibaldi and D. Perrier, "Multiple Dosing," in Pharmacokinetics (Marcel Dekker, Inc., New York, NY, 1982), pp. 113-144.
8. J.P. Skelly and W.H Barr, "Regulatory Assessment," in Controlled Drug Delivery: Fundamentals and Applications, J.R. Robinson and V.H.L Lee, Eds. (Marcel Dekker, Inc., New York, NY, 1987), pp. 293-334.
9. J. Urquhart, "How Much Compliance Is Enough?" Pharm. Res. 13 (1), 10-11(1996).
10. P.R. Chaturvedi, "Pharmacokinetics," in Encyclopedia of Controlled Drug Delivery, E. Methiowitz, Ed. (John Wiley and Sons, Inc, New York, NY, 1999), pp. 833-851.
11. P.J. Harrison, J.M. Newton, and R.C Row, "The Application of Capillary Rheometry to the Extrusion of Wet Powder Masses," Int. J. Pharm. 35 (3), 235-242 (1987).
12. J.A.C. Elbers, H. W. Bakkenes, and J.G. Fokkens, "Effect of Amount and Composition of Granulation Liquid on Mixing, Extrusion, and Spheronization," Drug Dev. Ind. Pharm. 18 (5), 501-517 (1992).
13. E. Eerikainen and A.-S. Lindqvist. "The Behaviour of Various Fillers in Spheronized Uncoated and Film-Coated Granules Containing Slightly Water Soluble Indomerhacin," Int. J. Pharm. 75 (2,3), 181-192 (1991).
14. R. Chatlapalli and B.D. Rohera, "Physical Characterization of HPMC and HEC and Investigation of Their Use as Pelletization Aids," Int. J. Pharm. 161 (2), 179-193 (1998).
15. K.E. Fielden et al., "Thermal Studies on the Interaction of Water and Microcrystalline Cellulose," J. Pharm. Pharmacol. 40 (10), 674-678 (1988).
16. D. Bains, S.L. Boutell, and M. Newton, "The Influence of Moisture Content on the Preparation of Spherical Granules of Barium Sulfate and Microcrystalline Cellulose," Int. J. Pharm. 69 (3), 233-237 (1991).
17. N.A. Peppas, "Analysis of Fickian and Non-Fickian Drug Release from Polymers," Pharm. Acta. Helv. 60, 110-111 (1985).
18. P.L. Ritger and N.A. Peppas, "A Simple Equation for Description of Solute Release II: Fickian and Anomalous Release from Swellable Devices," J. Controlled Release 5 (1), 37-42 (1987).
19. R.L. Ritger and NA Peppas, "A Simple Equation for Description of Solute Release: I. Fickian and Non-Fickian Release from Non-Swellable Devices in the Form of Slabs, Spheres, Cylinders or Disks," J. Controlled Release 5(1), 23-36(1987).
20. S.S. Davis et al., "The Effect of Food on the Intestinal Transit of Pellets and an Osmotic Device (Osmet)," Int. J. Pharm. 21 (3), 331-340 (1984).
21. A. Coupe, S.S. Davis, and I.R Wilding, "Variation in Gastrointestinal Transit of Pharmaceutical Dosage Forms in Healthy Subjects," Pharm. Res. 8 (3), 360-364 (1991).
22. G.M. Clarke, J.M. Newton, and M.D. Short, "Gastrointestinal Transit of Pellets of Differing Size and Density," Int. J. Pharm. 100 (1-3), 81-92 (1993).
23. W.I. Wilding, C.J. Kenyon, and G. Hooper, "Gastrointestinal Spread of Oral Prolonged-Release Mesalazine Microgranules (Pentasa) Dosed as Either Tablets or Sachet," Ailment Pharmacol. Ther. 14, 163-169 (2000).